IMR Press / FBL / Volume 17 / Issue 7 / DOI: 10.2741/4080

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Phage in the diagnosis and treatment of tuberculosis
Show Less
1 Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Chongqing Medical University, 400016, China
Academic Editor:Fei He
Front. Biosci. (Landmark Ed) 2012, 17(7), 2691–2697; https://doi.org/10.2741/4080
Published: 1 June 2012
(This article belongs to the Special Issue Cellular immunology and stem cell biology)
Abstract

The serious global TB epidemic coupled with limited diagnostic and therapeutic technologies necessitate the study of the role phage in TB treatment. Mycobacterium phage have been used for TB diagnosis, but the accuracy of such methods needs to be improved. Phage have various advantages in treating many kinds of bacterial infection, and coupled with the abuse and misuse of antibiotics, and the increasing prevalence of drug-resistant bacteria, they have been studied as a novel therapy to support antibiotics. The study of phage in TB therapy has developed from the selection of appropriate phage to the simultaneous use of multiple phage and even the use of purified lyase proteins. Though phage have great potential in TB therapy, the technology is still in the in vitro and animal experiment stages, and needs further study.

Share
Back to top